Search for the best prices     on the Internet!

Cholesterol: 80 years since St. Petersburg 1
Remnant lipoprotein metabolism 7
The plurimetabolic syndrome and the study of men born in 1913, Goteborg, Sweden 17
The plurimetabolic syndrome and the Paris Prospective Study 25
An epidemiologic view of the plurimetabolic syndrome: The Brisighella study 31
The plurimetabolic syndrome in animals: Models for experimentation, their implications and relation to NIDDM 45
Regulation of glucose transporter and hexokinase gene expression during development 57
Genetics of causes and manifestations of the metabolic syndrome 67
Fate of glucose in insulin resistant states 75
The possible pathophysiology of insulin resistance syndrome 83
Alterations of intracellular glucose metabolism in the insulin-resistant states 91
The role of fat distribution in the development of the plurimetabolic syndrome 99
Muscle capillarisation and morphology and pathogenesis of metabolic syndrome 105
Towards understanding renal structure and function in type 2 diabetes mellitus 121
Microalbuminuria, elevated blood pressure and the metabolic syndrome 127
Albuminuria and cardiovascular disease in diabetes mellitus: The role of endothelial dysfunction 133
Microalbuminuria as a risk factor for cardiovascular disease in non-diabetic subjects 141
Abnormalities of cation transport systems in non-insulin-dependent diabetes mellitus 153
Impaired peripheral glucose uptake in non-insulin dependent diabetic patients with hypertension and microalbuminuria 161
Insulin resistance and dyslipidemia 175
Lipid and lipoprotein anomalies in non-insulin dependent diabetes 181
Associations between LDL subclass phenotypes and the risk factors of the insulin resistance syndrome 189
The lipoprotein metabolism in the plurimetabolic syndrome 197
Familial association of dyslipidemia and hypertension 201
Lipoproteins, hypertension, microalbuminuria and insulin resistance in type 2 diabetes 209
Lipid and lipoprotein abnormalities and diabetic complications 215
The plurimetabolic syndrome and the haemocoagulation system 229
Impaired fibrinolysis as a part of the pluri-metabolic syndrome 239
Effect of triglycerides and triglyceride rich lipoproteins on fibrinolytic system 291
Dietary treatment of the plurimetabolic syndrome 249
Modifications of metabolic abnormalities after massive weight loss 255
Treatment of hyperlipidemia in plurimetabolic syndrome 271
Treatment of diabetes mellitus in patients with plurimetabolic syndrome 279
Index of authors 299